Health Promotion Research Institute, Korea Association of Health Promotion, Seoul, South Korea.
Division of Cardiology, Department of Internal Medicine, Korea Association of Health Promotion, Seoul, South Korea.
BMJ Open. 2019 Apr 20;9(4):e026030. doi: 10.1136/bmjopen-2018-026030.
Stage B heart failure (HF) is defined as an asymptomatic abnormality of the heart structure or function. The circulating level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) is elevated in symptomatic patients with left ventricular (LV) dysfunction caused by a structural or functional abnormality. This study investigated the association of the NT-proBNP level with echocardiography-detected cardiac structural or diastolic abnormalities in asymptomatic subjects with preserved LV systolic function (ejection fraction >50%).
We retrospectively studied 652 health examinees who underwent echocardiography and an NT-proBNP test at a health-promotion centre in Seoul, between January 2016 and September 2018. The left ventricular mass index (LVMI) and the left atrial dimension (LAD) were used as markers for structural abnormalities, and the mean e' velocity and mitral early flow velocity/early diastolic tissue velocity (E/e') ratio were used as markers for diastolic dysfunction. The plasma NT-proBNP level was measured using electrochemiluminescence immunoassay (DPC Immulite 2000 XPi, Siemens Healthcare Diagnostics, Tarrytown, New York, USA).
Subjects with preclinical structural abnormalities were older and had a higher body mass index (BMI), higher blood pressure, lower high-density lipoprotein cholesterol level, higher NT-proBNP level, and higher E/e' (p<0.05). Multivariate regression analysis indicated that the factors associated with a higher NT-proBNP level were older age, female sex, lower BMI, higher creatinine level, higher LVMI and higher LAD (p<0.01).
Diastolic dysfunction is not associated with higher NT-proBNP levels, whereas preclinical cardiac structural abnormalities, as well as older age, female sex, lower BMI, and higher creatinine level, are associated with higher NT-proBNP levels.
B 期心力衰竭(HF)定义为心脏结构或功能的无症状异常。循环中的 N 末端 B 型利钠肽原(NT-proBNP)水平在因结构或功能异常导致左心室(LV)功能障碍的有症状患者中升高。本研究调查了无症状左心室射血分数(EF)>50%保留收缩功能患者中 NT-proBNP 水平与超声心动图检测到的心脏结构或舒张异常的相关性。
我们回顾性研究了 2016 年 1 月至 2018 年 9 月在首尔健康促进中心接受超声心动图和 NT-proBNP 检测的 652 名健康体检者。左心室质量指数(LVMI)和左心房内径(LAD)用于标记结构异常,平均 e'速度和二尖瓣早期血流速度/早期舒张组织速度(E/e')比值用于标记舒张功能障碍。使用电化学发光免疫测定法(DPC Immulite 2000 XPi,西门子医疗诊断,纽约塔里敦,美国)测量血浆 NT-proBNP 水平。
有临床前结构异常的受试者年龄较大,体重指数(BMI)较高,血压较高,高密度脂蛋白胆固醇水平较低,NT-proBNP 水平较高,E/e'较高(p<0.05)。多变量回归分析表明,与较高 NT-proBNP 水平相关的因素是年龄较大、女性、BMI 较低、肌酐水平较高、LVMI 和 LAD 较高(p<0.01)。
舒张功能障碍与较高的 NT-proBNP 水平无关,而临床前心脏结构异常以及年龄较大、女性、BMI 较低和肌酐水平较高与较高的 NT-proBNP 水平相关。